AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hourly Market Review - Jun 12, 2025 10 AM
Generated by AI AgentAinvest Market Brief
Thursday, Jun 12, 2025 11:00 am ET1min read
Movers of the hour:
Liminatus Pharma is up 49.59% at $16.62.
Curevac is up 37.84% at $5.61.
TELUS International is up 19.93% at $3.55.
Arrive AI is up 19.88% at $10.22.
Sagimet Biosciences is up 18.26% at $7.32.
Here are the top stocks upgraded by Wall Street analyst:
Microsoft has received a rating of Strong Buy from Citigroup with target price increased to $605 from $540.
Microsoft has received a rating of Buy from RBC Capital with target price increased to $525 from $525.
Microsoft has received a rating of Buy from Evercore ISI Group with target price increased to $515 from $500.
Microsoft has received a rating of Strong Buy from Goldman Sachs with target price increased to $550 from $480.
Microsoft has received a rating of Strong Buy from Citigroup with target price increased to $540 from $480.
Nvidia has received a rating of Strong Buy from Benchmark with target price increased to $190 from $190.
Nvidia has received a rating of Strong Buy from Needham with target price increased to $160 from $160.
Nvidia has received a rating of Strong Buy from Rosenblatt with target price increased to $200 from $178.
Nvidia has received a rating of Neutral from DA Davidson with target price increased to $135 from $120.
Nvidia has received a rating of Buy from Barclays with target price increased to $170 from $155.
Ainvest Market Brief
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Morning Market Pulse: Trump Housing Overhaul & AI Surge Drive Pre-Market Moves
Dec.22 2025
Morning Market Pulse: Trump’s Federal Pay Raise & Japan’s Policy Shift Drive Pre-Market Moves
Dec.19 2025
What to Trade Today: Volatility and Inflows Drive Pre-Market Moves
Dec.19 2025
U.S. Corporate Actions | Ticker Changes and Dividend Announcements Highlight Activity
Dec.19 2025
Morning Market Pulse: Trump’s Marijuana Rescheduling and AI Policy Shifts
Dec.18 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet